First World Congress on
Mitochondria and Microbiota: Crucial Impact
Discussions will revolve around the dual role of EVs in mitochondrial function. They are instrumental in optimizing mitochondrial function by transferring proteins and genetic materials, which is vital for targeted drug delivery. However, they also pose risks by spreading damaged mitochondrial components, contributing to disease progression. The latest research in this field aims at biomarker discovery and regenerative approaches in mitochondrial medicine.
This segment will focus on microbiota-derived EVs and their significant role in health and disease. They facilitate communication among microorganisms and influence host cells, serving as potential biomarkers. These interactions between host-derived EVs and the microbiota offer promising therapeutic strategies for immune modulation, microbial balance restoration, and treating microbiota-related diseases.
Targeting EVs 2024 Program
Speakers Line-Up
Role of Stem Cell-Derived Extracellular Vesicles to Promote Successful Aging
Consuelo Borrás, University of Valencia, Spain
Extracellular Vesicle Release of Mitochondria in Response to Lysosomal Dysfunction
Åsa B. Gustafsson, University of California San Diego, USA
Liposomes & Exosomes: Lessons & Perspectives
Volkmar Weissig, Midwestern University, College of Pharmacy Glendale, USA
Delivery of Mitochondria-Containing EVs to the Blood-Brain Barrier
Devika S. Manickam, Duquesne University, USA
The Role of Mitovesicles in the Brain with Mitochondrial Dysfunction
Efrat Levy, NYU Grossman School of Medicine, USA
Microbiota-Derived Extracellular Vesicles in Maternal-Fetal Communication: What We Know?
Justus Reunanen, University of Oulu, Finland
Engineering Exosomes for Precise Mitochondrial Targeting in Brain Cells: Expanding the Frontiers of Cellular Communication and Therapeutics
Lanrong Bi, Michigan Technological University, USA
Mitochondrial DAMPs in EVs: Triggering Early Neuroinflammation in Neurodegeneration
Carla Lopes, University of Coimbra, Portugal
Therapeutic Applications of Microbial Extracellular Vesicles
Steven Jay, University of Maryland, USA
Targeting central regulation of obesity with EVs: Breakthrough Approach Nature Metabolism
Ramaroson Andriantsitohaina, University of Montpellier, France
Exploring the Capabilities of Exosomes from Muscle-Derived Mesenchymal Stem Cells: Insights into Immunomodulation and Mitochondrial Transfer
Didier Serteyn, Université de Liège, Belgium
Cancer-related Extracellular Vesicles in relation to Mitochondria, Microbiota and More
Lorraine O’Driscoll, Trinity College Dublin and Trinity St. James's Cancer Institute, Ireland
Bioinspired, Fully Synthetic Extracellular Vesicles to Optimize Wound Healing
Joachim Pius Spatz, University of Heidelberg, Germany
Modulation of Phage-Microbe interactions and Antimicrobial Resistance by Bacterial Extracellular Vesicles
Meta Kuehn, Duke University, USA
Lactobacilli Extracellular Vesicles: Potential Postbiotics to Support The Vaginal Microbiota Homeostasis
Carola Parolin, University of Bologna, Italy
Gut-Microbiome Derived Extracellular Vesicles in Cancer
Surbhi Mishra, University of Oulu, Finland
The gut microbe-derived extracellular vesicles (GMEVs)- mitochondria axis in mental disorders: Strengths and weaknesses of new studies
Seyed Davar Siadat, Pasteur Institute of Iran, Iran
Book Your Room at the Congress Hotel for Reduced Rate
Secure your accommodation now at the Congress Hotel, Corinthia Palace, for Targeting EVs 2024 at a discounted rate exclusively for attendees.
